Medication taking in the management of chronic conditions causes a significant burden on individuals. The aim of this study was to explore the medication-related burden in ambulatory adult patients with chronic conditions in Malta.
Methods
A cross-sectional survey utilising the living with medicines questionnaire V3 (LMQ V3) was conducted in Maltese residents over the age of 18 years, taking at least 1 medication for a chronic condition and recruited through community events. The overall LMQ score, the domain scores and the visual analog scale data were analysed to determine relationships with the demographic factors.
Results
A total of 337 responses were analysed revealing a moderate (42.4%) to high medication (36.8%) related burden. The drivers of medication-related burden were primarily: ‘side-effects of prescribed medication’ (r = −0.843, p < 0.001), ‘attitudes/concerns about medicine use’ (r = −0.830, p < 0.001) and ‘impact/interferences to day-to-day life’ (r = −0.820, p < 0.001). Lack of autonomy to vary the dosage regimen resulted in a higher burden (r = −0.260, p < 0.001). Males experienced an overall higher burden (p = 0.046) especially related to practical difficulties (p = 0.04), cost-related burden (p = 0.04) and side-effects of prescribed medication (p = 0.01).
Conclusion
Medication-related burden is complex and multi-faceted as demonstrated by the findings of this study. Healthcare professionals should seek to identify and address factors causing this burden to improve patient outcomes.
The World Health Organisation. The European Programme of Work, 2020–2025 united action for better health. Copenhagen: WHO Regional Office for Europe. 2021
2.
HughesC. Appropriate and inappropriate polypharmacy-choosing the right strategy. Br J Clin Pharmacol2021; 87: 84–86.
3.
RankinACadoganCAPattersonSM, et al.Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev2018; 9: CD008165.
4.
CadoganCARyanCHughesCM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf2016; 39: 109–116.
5.
GormanARankinAHughesC, et al.Theoretically derived interventions aimed at improving appropriate polypharmacy in primary care: a systematic review. Explor Res Clin Soc Pharm2022; 7: 100166.
6.
KrskaJMorecroftCWPooleH,et al.Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm2013; 35: 1161–1169.
7.
MohammedMAMolesRJChenTF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open2016; 6: e010035.
8.
SavAKendallEMcMillanSS, et al. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Community2013; 21: 665–674.
9.
SavAMcMillanSSKellyF, et al.The ideal healthcare: priorities of people with chronic conditions and their carers. BMC Health Serv Res2015; 15: 551.
10.
OlssonINRunnamoREngfeldtP. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes2011; 9: 95.
11.
ZaninottoPHuangYTDi GessaG,et al.Polypharmacy is a risk factor for hospital admission due to a fall: evidence from the English longitudinal study of ageing. BMC Public Health2020; 20: 1804.
12.
The World Health Organisation. Medication safety in polypharmacy. Geneva: World Health Organization, (WHO/UHC/SDS/2019.11). 2019
13.
LatifAMandaneBAliA,et al.A qualitative exploration to understand access to pharmacy medication reviews: views from marginalized patient groups. Pharmacy2020; 8: 73.
14.
DoumatGDaherDItaniM, et al.The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study. BMC Prim Care2023; 24: 20.
15.
LinkensAEMJHMilosevicVvan der KuyPHM, et al.Medication-related hospital admissions and readmissions in older patients: an overview of literature. Int J Clin Pharm2020; 42: 1243–1251.
16.
WeinerSJSchwartzAWeaverF, et al.Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med2010; 153: 69–75.
17.
McCulloughARRyanCO’NeillB, et al.Defining the content and delivery of an intervention to change AdhereNce to treatment in BonchiEctasis (CAN-BE): a qualitative approach incorporating the theoretical domains framework, behavioural change techniques and stakeholder expert panels. BMC Health Serv Res2015; 15: 342.
UN General Assembly. Transforming our world: the 2030 Agenda for Sustainable Development, 21 October 2015, A/RES/70/1, https://www.refworld.org/docid/57b6e3e44.html (accessed 15 September 2022).
HazraA. Using the confidence interval confidently. J Thorac Dis2017; 9: 4125–4130.
24.
KrskaJKatusiimeBCorlettSA. Validation of an instrument to measure patients’ experiences of medicine use: the living with medicines questionnaire. Patient Prefer Adherence2017; 11: 671–679.
25.
GattIWestLMCallejaN, et al.Psychometric properties of the belief about medicines questionnaire (BMQ) in the Maltese language. Pharm Pract (Granada)2017; 15: 886.
26.
Joint Formulary Committee. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; [updated 2018 Mar 21; cited 2019 Apr 9], https://bnf.nice.org.uk/
27.
WangYKrskaJLinB, et al.Cross-cultural adaptation and reliability testing of Chinese version of the living with medicines questionnaire in elderly patients with chronic diseases. Patient Prefer Adherence2020; 14: 2477–2487.
28.
AwadAAlhadabAAlbassamA. Medication-related burden and medication adherence among geriatric patients in Kuwait: a cross-sectional study. Front Pharmacol2020; 11: 1296.
29.
TordoffJMBrenkleyCKrskaJ, et al.Exploring medicines burden among adults in New Zealand: a cross-sectional survey. Patient Prefer Adherence2019; 13: 2171–2184.
30.
KrskaJKatusiimeBCorlettSA. Patient experiences of the burden of using medicines for long-term conditions and factors affecting burden: a cross-sectional survey. Health Soc Care Community2018; 26: 946–959.
31.
ZidanAAwaisuAEl-HajjMS, et al.Medication-related burden among patients with chronic disease conditions: perspectives of patients attending non-communicable disease clinics in a primary healthcare setting in Qatar. Pharmacy (Basel)2018; 6: 85.
32.
ByromBElashCAEremencoS, et al.Measurement comparability of electronic and paper administration of visual analogue scales: a review of published studies. TIRS2022; 56: 394–404.
33.
ChenWSIslamMRAmbepitiyaS, et al.Factors associated with patient experiences of the burden of using medicines and health-related quality of life: a cross-sectional study. PLoS One2022; 17: e0267593.
34.
DiMatteoMR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary1995; 30: 596–598, 601–602, 605.
35.
GopichandranVChetlapalliSK. Factors influencing trust in doctors: a community segmentation strategy for quality improvement in healthcare. BMJ Open2013; 3: e004115.
36.
National Statistical Office. Regional statistics Malta. Valletta, Malta: Communication and Dissemination Unit, 2021.
37.
ChapmanSCHorneRChaterA, et al.Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav2014; 31: 312–320.
38.
EtonDTRamalho de OliveiraDEggintonJS, et al.Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas2012; 3: 39–49.
39.
BajcarJ. Task analysis of patients’ medication-taking practice and the role of making sense: a grounded theory study. Res Social Adm Pharm2006; 2: 59–82.
40.
ParkHYSeoSAYooH, et al.Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Patient Prefer Adherence2018; 12: 175–181.
41.
Volpicelli LeonardKRobertsonC, et al.Perceived treatment satisfaction and effectiveness facilitators among patients with chronic health conditions: a self-reported survey. Interact J Med Res2020; 9: e13029.
42.
HorneRChapmanSCParhamR, et al.Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One2013; 8: e80633.
